147 related articles for article (PubMed ID: 35389352)
1. A Study on Prevalence and Determinants of Ototoxicity During Treatment of Childhood Cancer (SOUND): Protocol for a Prospective Study.
Diepstraten FA; Meijer AJ; van Grotel M; Plasschaert S; Hoetink AE; Fiocco M; Janssens GO; Stokroos RJ; van den Heuvel-Eibrink MM
JMIR Res Protoc; 2022 Apr; 11(4):e34297. PubMed ID: 35389352
[TBL] [Abstract][Full Text] [Related]
2. Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study.
Clemens E; Meijer AJ; Broer L; Langer T; van der Kooi AL; Uitterlinden AG; de Vries A; Kuehni CE; Garrè ML; Kepak T; Kruseova J; Winther JF; Kremer LC; van Dulmen-den Broeder E; Tissing WJ; Rechnitzer C; Kenborg L; Hasle H; Grabow D; Parfitt R; Binder H; Carleton BC; Byrne J; Kaatsch P; Am Zehnhoff-Dinnesen A; Zolk O; van den Heuvel-Eibrink MM
JMIR Res Protoc; 2019 Mar; 8(3):e11868. PubMed ID: 30888333
[TBL] [Abstract][Full Text] [Related]
3. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
4. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
6. Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program.
Paken J; Govender CD; Sewram V
BMC Womens Health; 2017 Dec; 17(1):129. PubMed ID: 29228931
[TBL] [Abstract][Full Text] [Related]
7. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
Clemens E; de Vries AC; Pluijm SF; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; van Grotel M; van den Heuvel-Eibrink MM;
Eur J Cancer; 2016 Dec; 69():77-85. PubMed ID: 27821322
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa.
Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
BMC Cancer; 2021 Jul; 21(1):822. PubMed ID: 34271863
[TBL] [Abstract][Full Text] [Related]
9. Ototoxicity and cancer therapy.
Landier W
Cancer; 2016 Jun; 122(11):1647-58. PubMed ID: 26859792
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
Trendowski MR; Baedke JL; Sapkota Y; Travis LB; Zhang X; El Charif O; Wheeler HE; Leisenring WM; Robison LL; Hudson MM; Morton LM; Oeffinger KC; Howell RM; Armstrong GT; Bhatia S; Dolan ME
Cancer; 2021 Nov; 127(21):4091-4102. PubMed ID: 34286861
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside- and glycopeptide-induced ototoxicity in children: a systematic review.
Diepstraten FA; Hoetink AE; van Grotel M; Huitema ADR; Stokroos RJ; van den Heuvel-Eibrink MM; Meijer AJM
JAC Antimicrob Resist; 2021 Dec; 3(4):dlab184. PubMed ID: 34917943
[TBL] [Abstract][Full Text] [Related]
13. [Ototoxicity in cancer survivors: experience and proposal of a surveillance protocol].
Sánchez-Canteli M; Núñez-Batalla F; Martínez-González P; de Lucio-Delgado A; Villegas-Rubio JA; Gómez-Martínez JR; Llorente-Pendás JL
An Pediatr (Engl Ed); 2020 Sep; ():. PubMed ID: 32998843
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study.
Zolk O; von dem Knesebeck A; Graf N; Simon T; Hero B; Abdul-Khaliq H; Abd El Rahman M; Spix C; Mayer B; Elsner S; Gebauer J; Langer T
JMIR Res Protoc; 2022 Feb; 11(2):e27898. PubMed ID: 35175211
[TBL] [Abstract][Full Text] [Related]
15. An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy.
Brown ECM; Caimino C; Benton CL; Baguley DM
J Laryngol Otol; 2021 Jan; 135(1):14-20. PubMed ID: 33487183
[TBL] [Abstract][Full Text] [Related]
16. Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study.
Smit M; van Pelt G; Roodvoets A; Meershoek-Klein Kranenbarg E; Putter H; Tollenaar R; van Krieken JH; Mesker W
JMIR Res Protoc; 2019 Jun; 8(6):e13464. PubMed ID: 31199317
[TBL] [Abstract][Full Text] [Related]
17. Ototoxicity in cancer survivors: Experience and proposal of a surveillance protocol.
Sánchez-Canteli M; Núñez-Batalla F; Martínez-González P; de Lucio-Delgado A; Antonio Villegas-Rubio J; Gómez-Martínez JR; Luis Llorente-Pendás J
An Pediatr (Engl Ed); 2021 Nov; 95(5):290-297. PubMed ID: 34702687
[TBL] [Abstract][Full Text] [Related]
18. Challenges in ototoxicity monitoring in the pediatric oncology population.
Bass JK; Bhagat SP
J Am Acad Audiol; 2014 Sep; 25(8):760-74; quiz 782-3. PubMed ID: 25380122
[TBL] [Abstract][Full Text] [Related]
19. Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors.
Romano A; Rivetti S; Brigato F; Mastrangelo S; Attinà G; Maurizi P; Galli J; Fetoni AR; Ruggiero A
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830798
[TBL] [Abstract][Full Text] [Related]
20. Ototoxicity monitoring in South African cancer facilities: A national survey.
Ehlert K; Heinze B; Swanepoel W
S Afr J Commun Disord; 2022 Jan; 69(1):e1-e10. PubMed ID: 35144440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
